Discovery of pyrimidine-based dual CDK2/TrkA inhibitors: Synthesis, antiproliferative activity, and mechanistic insights.

Slly AM, Ewes WA, Bayoumi WA, Selim KB

Open source

DOI
10.1016/j.bioorg.2026.110570
Published
2026 Sep 23
Container
Bioorganic chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bioorg.2026.110570,
  title = {Discovery of pyrimidine-based dual CDK2/TrkA inhibitors: Synthesis, antiproliferative activity, and mechanistic insights.},
  author = {Slly AM and Ewes WA and Bayoumi WA and Selim KB},
  year = {2026},
  journal = {Bioorganic chemistry},
  doi = {10.1016/j.bioorg.2026.110570},
  url = {https://doi.org/10.1016/j.bioorg.2026.110570}
}

RIS

TY  - JOUR
TI  - Discovery of pyrimidine-based dual CDK2/TrkA inhibitors: Synthesis, antiproliferative activity, and mechanistic insights.
AU  - Slly AM
AU  - Ewes WA
AU  - Bayoumi WA
AU  - Selim KB
PY  - 2026
JO  - Bioorganic chemistry
DO  - 10.1016/j.bioorg.2026.110570
UR  - https://doi.org/10.1016/j.bioorg.2026.110570
ER  - 

APA

AM, S., WA, E., WA, B., & KB, S. (2026). Discovery of pyrimidine-based dual CDK2/TrkA inhibitors: Synthesis, antiproliferative activity, and mechanistic insights.. Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2026.110570

Source records